🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multi-center, global phase II/III clinica...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2026-05-27
Trial ID
NCT07459751
Treatments Being Tested
The study is being conducted to to explore the reasonable dosage and evalua...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-29
Trial ID
NCT07301229
Treatments Being Tested
The study is being conducted to explore the reasonable dosage and evaluate ...
Status
Recruiting
Location
Hunan Provincial Cancer Hospital
Start Date
2025-02-25
Trial ID
NCT06848699
Treatments Being Tested
This study is a phase Ib/II study to evaluate the efficacy, safety and tole...
Status
Not Yet Recruiting
Location
Sun Yat-Sen University Cancer Center
Start Date
2026-01-31
Trial ID
NCT07358585
Treatments Being Tested
The study is being conducted to to explore the reasonable dosage and evalua...
Status
Recruiting
Location
MD Anderson Cancer Hospital
Start Date
2025-06-09
Trial ID
NCT06907615
Treatments Being Tested
The study is being conducted to to explore the reasonable dosage and evalua...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-15
Trial ID
NCT07115485
Treatments Being Tested
The study is being conducted to to explore the reasonable dosage and evalua...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2026-01-20
Trial ID
NCT07269782
Treatments Being Tested
The study is being conducted to to explore the reasonable dosage and evalua...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-15
Trial ID
NCT07106892
Treatments Being Tested
The study is being conducted to explore the reasonable dosage and evaluate ...
Status
Recruiting
Location
Shandong Cancer Hospital
Start Date
2025-02-20
Trial ID
NCT06769152
Treatments Being Tested
This is a Phase II Study of HLX43 in Hormone Receptor Positive，HER-2 negati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07459738
Treatments Being Tested